Navigation Links
Global Genitourinary Drugs Market 2011-2015 Report Reveals That One of the Major Challenges Is the Increase in the Patent Expiries of the Best-Selling Drugs in the Market
Date:12/3/2013

DUBLIN, December 3, 2013 /PRNewswire/ --

Research and Markets ( http://www.researchandmarkets.com/research/67g6vc/global) has announced the addition of the "Global Genitourinary Drugs Market 2011-2015" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

TechNavio's analysts forecast the Global Genitourinary Drugs market to grow at a CAGR of 3.05 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel biological drugs. The Global Genitourinary Drugs market has also been witnessing a paradigm shift toward biological drugs. However, lack of adherence to medication could pose a challenge to the growth of this market.

The key vendors dominating this space are Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Eli Lilly and Co., GlaxoSmithKline plc, Merck and Co. Inc., and Pfizer Inc.

Other vendors mentioned in the report are Agile Therapeutics Inc., Allergan Inc., Antares Pharma Inc., Boehringer Ingelheim GmbH, Dong-A Pharmaceutical Co. Ltd., Detrol LA, Ferring Holding S.A., Kissei Pharmaceutical Co. Ltd., Merck Serono S.A., Novartis International AG, Novo Nordisk A/S, Nymox Pharmaceutical Corp., PregLem S.A., Recordati S.p.A., Rottapharm S.p.A., Teva Pharmaceutical Industries Ltd., VIVUS Inc., Warner Chilcott plc, and Watson Pharmaceuticals Inc.

Commenting on the report, an analyst from TechNavio's Healthcare team said: "Patients suffering from infections and disorders related to genitourinary systems are using steroids and immunosuppressants. However, these medications cause serious side effects because they are chemically synthesized. Hence, patients are turning to biological drugs that not only cause fewer side effects, but are also more effective in the treatment of genitourinary infection. Moreover, there has been an increase in the number of biological drugs entering the Global Genitourinary Drugs market."

According to the report, one of the major growth factors driving the Global Genitourinary Drugs market is the entry of novel drugs such as Cialis which are more effective than the drugs used in multiple-drug therapies. These novel drugs provide cost-effective treatment for genitourinary infection.


For more information visit http://www.researchandmarkets.com/research/67g6vc/global

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Xlumena Closes Series C Financing; Focuses on Expanding Global Commercial Presence and Obtaining FDA Clearance
2. Bone Densitometers Market is Expected to Reach USD 908.5 Million Globally in 2019: Transparency Market Research
3. The Global Fund Replenishment Partners Talk Shared Responsibility
4. Spectrometers And Spectrophoto/Fluorometers - 2012 Global Strategic Business Report with Forecasts to 2018
5. Global Urological Catheters (Dialysis & Urinary) Strategic Business Report 2013-2018: Urinary Catheters Take the Lead
6. Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation
7. Natural Source Vitamin E (Tocopherols and Tocotrienols) - A Global Market Overview
8. InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
9. NineSigma, GE Announce Selection of 10 Finalists in GE Global 3D Printing Production Quest
10. Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business
11. Global Electronics Market 2018 Forecasts for 6 Sectors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017  HealthMine surveys with 9,250 insured consumers fielded ... plan members want help from their plans in five ... their health, 2) help closing gaps in care, 3) ... and 5) relevant, real-time guidance. Meeting these needs is ... A Reason to Stay Engaged ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... The Global Cryostat Market ... the next decade to reach approximately $3.5 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:3/23/2017)... -- Executive Summary ... research (inputs from industry experts, companies, stakeholders) and ... analysis of global heart valve devices market on ... Procedure By Technique (Mechanical, Bioprosthetic, Transcatheter Aortic Valve ... Valvuloplasty, Transcatheter Mitral Valve Repair (TMVR)), By Region ...
Breaking Medicine Technology:
(Date:3/24/2017)... , ... March 24, 2017 , ... According to a ... is invalid because it does not obey the rules Congress has directed the CBO ... jobs, which the GOP reform would restore. Yet, it estimates a reduction in employer-based ...
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier provider ... caring for those suffering from the full spectrum of disordered eating, announced today that ... professionals from nearly all 50 states and several countries converged on the Green Valley ...
(Date:3/24/2017)... ... 2017 , ... Shamanic healer and teacher Anahata Ananda of ... Awakening, proudly presents her Sacred Peru retreat with world famous shaman and ... during the Summer Solstice will also be her final international retreat, Anahata announced ...
(Date:3/24/2017)... ... March 24, 2017 , ... As the ... create a communications platform that positions them as the go-to thought leader in ... their online publication as an always-on, always-fresh news, views and advocacy engine, called ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... two panels at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. ... the Administrative Record, The majority of cases litigated under ERISA involve claims for ...
Breaking Medicine News(10 mins):